James Signorovitch
James Signorovitch publishes mostly in Pulmonary and Respiratory Medicine, Molecular Biology and Economics and Econometrics, on topics such as Muscle Physiology and Disorders, Lung Cancer Treatments and Mutations and Economic and Financial Impacts of Cancer.
- World rank
- #1,058,039 of 1,633,909 ranked researchers
- Rank in United States
- #273,501 of 358,040
- Works
- 70
- Citations
- 60
- Citations per work
- 0.9
What does James Signorovitch research?
Shares of their own output, by the field each of their topics belongs to. The grey slice is everything not listed.
- 1Pulmonary and Respiratory Medicine14% of their works
- 2Molecular Biology9% of their works
- 3Economics and Econometrics9% of their works
- 4Oncology7% of their works
- 5Genetics5% of their works
- 6Physiology5% of their works
Research topics
- Muscle Physiology and Disorders
- Lung Cancer Treatments and Mutations
- Economic and Financial Impacts of Cancer
- Cancer Genomics and Diagnostics
- Statistical Methods in Clinical Trials
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Colorectal Cancer Treatments and Studies
- Advanced Breast Cancer Therapies
Which keywords describe James Signorovitch's research?
The keywords of their largest research topics: Targeted Therapy, ALK Inhibitors, Cost of Care, EGFR Mutations, Financial Toxicity, Muscle Regeneration, Skeletal Muscle Atrophy and Adaptive Designs.
- Mutational Signatures
- JAK2 Mutation
- Cetuximab
- CDK4/6 Inhibitors
- Adaptive Designs
- Muscle Regeneration
- EGFR Mutations
- ALK Inhibitors
- Targeted Therapy
- Cost of Care
- Financial Toxicity
- Skeletal Muscle Atrophy
- Breast Cancer
- Cancer Genomics
- False Discovery Rate
- KRAS Mutations
- Myelofibrosis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 17 words, with their numbers
- Targeted Therapy72 topics
- ALK Inhibitors41 topic
- Cost of Care41 topic
- EGFR Mutations41 topic
- Financial Toxicity41 topic
- Muscle Regeneration41 topic
- Skeletal Muscle Atrophy41 topic
- Adaptive Designs31 topic
- Breast Cancer31 topic
- CDK4/6 Inhibitors31 topic
- Cancer Genomics31 topic
- Cetuximab31 topic
- False Discovery Rate31 topic
- JAK2 Mutation31 topic
- KRAS Mutations31 topic
- Mutational Signatures31 topic
- Myelofibrosis31 topic
Where does James Signorovitch work?
James Signorovitch's main affiliation in the publication record is Analysis Group (United States), United States.
How many publications and citations does James Signorovitch have?
Science Explorer counts 70 works and 60 citations for James Signorovitch, ranking #1,058,039 of 1,633,909 researchers worldwide on the composite score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics are in the interactive view on the map. Is this your page? Request a correction or removal.